Pharma firms plan awareness drive to battle cancer scare in antacid

Indian companies have also been hit in their global business.

Around four months earlier, the US drugs regulator said it had found a cancer-causing impurity in some products containing ranitidine, a popular prescription for acidity.
 
That has meant a major quake within the Indian pharmaceutical industry, since a number of its prominent members sell versions of this drug. India also happens to be the largest supplier of ranitidine's active pharmaceutical ingredient (API) to the world, with monthly  production capacity of 5,000 tonnes.
 
Both bulk drug and formulation players have been altering their manufacturing processes. The domestic market size for the formulation has since shrunk by at least 20